ATP6V0D2 Promotes Atherosclerosis‐Associated Vascular Smooth Muscle Cell Dysfunction by Modulating Ferroptosis‐Related Signaling
The Journal of Gene Medicine · 2026
DOI: 10.1002/jgm.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2026. Verfasst von Chaohui Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Ferroptosis, Atherosclerosis, Muscle, Smooth, Vascular, Signal Transduction. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Research Project for Universities of Anhui Province.
Abstract (Originalsprache)
Background
Atherosclerosis (AS) underlies a substantial proportion of cardiovascular morbidity and mortality, yet the molecular events that drive vascular cell injury remain only partly resolved.
Methods
We first compared aortic transcriptomes from apolipoprotein E‐deficient (ApoE−/−) mice maintained on control or high‐fat diets. Candidate‐gene effects were then examined in human vascular smooth muscle cells (HVSMCs) challenged with oxidized low‐density lipoprotein (ox‐LDL).
Results
The aortic dataset contained 2832 differentially expressed genes (1800 increased and 1032 decreased). Of the five genes taken forward, ATP6V0D2 displayed a graded increase as the ox‐LDL concentration rose. Network and enrichment results connected ATP6V0D2 to proton movement, acidification of intracellular organelles, and iron transport. Silencing ATP6V0D2 limited the ox‐LDL‐evoked accumulation of neutral lipid and restrained cell‐cycle entry, motility, and invasion. At the molecular level, knockdown lowered acyl‐CoA synthetase long‐chain family member 4 (ACSL4) and recovered solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4). It also raised glutathione (GSH) abundance and superoxide dismutase (SOD) activity while decreasing malondialdehyde (MDA), reactive oxygen species (ROS), mitochondrial contraction, and cristae damage. Ferrostatin‐1 shifted the molecular, redox, and ultrastructural readouts in the same direction.
Conclusions
These data identify ATP6V0D2 as a contributor to the abnormal HVSMC phenotypes produced by ox‐LDL. Its depletion appears to blunt this response, in part through attenuation of changes compatible with ferroptosis and warrants further evaluation as a mechanistic target for AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Zheng Huang
Förderung
- Natural Science Research Project for Universities of Anhui Province
Zitieren
APA
Zhang, C., Li, M., Wu, J., Hu, Z., Wang, X., Gao, F., & Huang, Z. (2026). ATP6V0D2 Promotes Atherosclerosis‐Associated Vascular Smooth Muscle Cell Dysfunction by Modulating Ferroptosis‐Related Signaling. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70113
Vancouver
Zhang C, Li M, Wu J, Hu Z, Wang X, Gao F, et al. ATP6V0D2 Promotes Atherosclerosis‐Associated Vascular Smooth Muscle Cell Dysfunction by Modulating Ferroptosis‐Related Signaling. The Journal of Gene Medicine. 2026. doi:10.1002/jgm.70113
BibTeX
@article{Zhang2026,
author = {Zhang, Chaohui and Li, Mengli and Wu, Jie and Hu, Zhangle and Wang, Xiaochen and Gao, Feng and Huang, Zheng},
title = {ATP6V0D2 Promotes Atherosclerosis‐Associated Vascular Smooth Muscle Cell Dysfunction by Modulating Ferroptosis‐Related Signaling},
journal = {The Journal of Gene Medicine},
year = {2026},
doi = {10.1002/jgm.70113}
}
EUVIMED